Assessment of inhomogeneities of repolarization in patients with systemic lupus erythematosus

Annals of Noninvasive Electrocardiology

Volumn 19, Issue 4, 2014, Pages 374-382

  Avci, Ahmet ^a   Demir, Kenan ^a   Altunkeser, Bulent Behlul ^a   Yilmaz, Sema ^a   Yilmaz, Ahmet ^a   Ersecgin, Ahmet ^a   Demir, Tarik ^a  

^a SELCUK UNIVERSITY   (Turkey)

Author keywords

arrhythmia; inhomogeneities of repolarization; systemic lupus erythematosus; Tp e interval; Tp e QT

Indexed keywords

C REACTIVE PROTEIN; CREATININE;

ADULT; ARTICLE; BODY MASS; BODY SURFACE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIASTOLIC BLOOD PRESSURE; DISEASE DURATION; ECHOCARDIOGRAPH; ELECTROCARDIOGRAM; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HEART RATE; HUMAN; LEUKOCYTE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; QT DISPERSION; QT INTERVAL; REPOLARIZATION; SMOKING; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTOLIC BLOOD PRESSURE; TRANSTHORACIC ECHOCARDIOGRAPHY; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; HEART MUSCLE CONDUCTION SYSTEM; PATHOPHYSIOLOGY;

ADULT; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; HEART CONDUCTION SYSTEM; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC;

EID: 84904697950     PISSN: 1082720X     EISSN: 1542474X     Source Type: Journal    
DOI: 10.1111/anec.12145     Document Type: Article

References (38)

1. Yu X-H, Li Y-N,. Echocardiographic abnormalities in a cohort of Chinese patients with systemic Lupus erythematosus-a retrospective analysis of eighty-five cases. J Clin Ultrasound 2011; 39: 519-526.
2. Duxbury B, Combescure C, Chizzolini C,. Rituximab in systemic lupus erythematosus: an updated systematic review and meta-analysis. Lupus 2013; 22: 1489-1503.
3. Moder KG, Miller TD, Tazelaar HD,. Cardiac involvement in systemic lupus erythematosus. Mayo Clin Proc 1999; 74: 275-284.
4. Svenungsson E, Jensen-Urstad K, Heimburger M, et al. Risk factors for cardiovascular disease in systemic lupus erythematosus. Circulation 2001; 104: 1887-1893.
5. Borchers AT, Keen CL, Shoenfeld Y, et al. Surviving the butterfly and the wolf: mortality trends in systemic lupus erythematosus. Autoimmun Rev 2004; 3: 423-453.
6. Petri M, Perez-Gutthann S, Spence D, et al. Risk factors for coronary artery disease in patients with systemic lupus erythematosus. Am J Med 1992; 93: 513-519.
7. Lazzerini PE, Acampa M, Guideri F, et al. Prolongation of the corrected QT interval in adult patients with anti-Ro/SSA-positive connective tissue diseases. Arthritis Rheum 2004; 50: 1248-1252.
8. Teixeira RA, Borba EF, Bonfa E, et al. Arrhythmias in systemic lupus erythematosus. Rev Bras Reumatol 2010; 50: 81-89.
9. Gupta P, Patel C, Patel H, et al. Tp-e/QT ratio as an index of arrhythmogenesis. J Electrocardiol 2008; 41: 567-574.
10. Mozos I, Serban C, Mihaescu R,. The relation between arterial blood pressure variables and ventricular repolarization parameters. Int J Collab Res Intern Med Public Health 2012; 4: 860-875.
11. Haapalahti P, Viitasalo M, Perhonen M, et al. Comparison of QT peak and QT end interval responses to autonomic adaptation in asymptomatic LQT1 mutation carriers. Clin Physiol Funct Imaging 2011; 31: 209-214.
12. Letsas KP, Weber R, Astheimer K, et al. Tpeak-Tendinterval and Tpeak-Tend/QT ratio as markers of ventricular tachycardia inducibility in subjects with Brugada ECG phenotype. Europace 2010; 12: 271-274.
13. Smetana P, Schmidt A, Zabel M, et al. Assessment of repolarization heterogeneity for prediction of mortality in cardiovascular disease: Peak to the end of the T wave interval and nondipolar repolarization components. J Electrocardiol 2011; 44: 301-308.
14. Zhao X, Xie Z, Chu Y, et al. Association between Tp-e/QT ratio and prognosis in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction. Clin Cardiol 2012; 35: 559-564.
15. Yavuz B, Atalar E, Karadag O, et al. QT dispersion increases in patients with systemic lupus erythematosus. Clin Rheumatol 2007; 26: 376-379.
16. Cardosa CRL, Sales MAO, Papi JAS, et al. QT-interval parameters are increased in systemic lupus erythematosus patients. Lupus 2005; 14: 846-852.
17. Kojuri J, Nazarinia MA, Gahahartas M, et al. QT dispersion in patients with systemic lupus erythematosus: the impact of disease activity. BMC Cardiovasc Disord 2012; 12: 11.
18. Abu-Shakra M,. Do improved survival rates of patients with systemic Lupus erythematosus reflect a global trend? J Rheumatol 2008; 35: 1906-1908.
19. Doria A, Iaccarino L, Sarzi-Puttini P, et al. Cardiac involvement in systemic lupus erythematosus. Lupus 2005; 14: 683-686.
20. Urowitz MB, Bookman AAM, Koehler BE, et al. The bimodal mortality pattern of SLE. Am J Med 1976; 60: 221-225.
21. D'Cruz D, Khamashta M, Huges GRV,. Cardiovascular manifestation of systemic lupus erythematosus. In, Wallace DJ, and, Hahn BH, (eds.): Dubois' Lupus Erythematosus. Philadelphia, Lippincott Williams & Wilkins, 2001, 645 p.
22. Kao AH, Manzi S,. How to manage patients with cardiopulmonary disease ? Best Pract Res Clin Rheumatol 2002; 16: 211-227.
23. Paran D, Caspi D, Levartovsky D, et al. Cardiac dysfunction in patients with systemic lupus erythematosus and antiphospholipid syndrome. Ann Rheum Dis 2007; 66: 506-510.
24. Sasson Z, Rasooly Y, Chow CW, et al. Impairment of left ventricular diastolic function in systemic lupus erythematosus. Am J Cardiol 1992; 69: 1629-1634.
25. Leung WH, Wong KL, Lau CP, et al. Doppler echocardiographic evaluation of left ventricular diastolic function in patients with systemic lupus erythematosus. Am Heart J 1990; 120: 82-87.
26. Pieretti J, Roman MJ, Devereux RB, et al. Systemic lupus erythematosus predicts increased left ventricular mass. Circulation 2007; 116: 419-426.
27. Seferovic PM, Ristic AD, Maksimovic R, et al. Cardiac arrhythmias and conduction disturbances in autoimmune rheumatic diseases. Rheumatology 2006; 45: 39-42.
28. Teixeira RA, Borba EF, Pedrosa A, et al. Evidence for cardiac safety and antiarrhythmic potential of chloroquine in systemic lupus erythematosus. Europace 2013 Sep 19 [Epub ahead of print].
29. Porthan K, Viitasalo M, Toivonen L, et al. Predictive value of electrocardiographic T-wave morphology parameters and T-wave peak to T-wave end interval for sudden cardiac death in the general population. Circ Arrhythm Electrophysiol 2013; 6: 690-696.
30. Rautaharju PM, Surawicz B, Gettes LS, et al. AHA/ACCF/HRS recommendations for the standardization and interpretation of the electrocardiogram: part IV: the ST segment, T and U waves, and the QT interval: a scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society: endorsed by the International Society for Computerized Electrocardiology. Circulation 2009; 119: 241-250.
31. Antzelevitch C, Shimizu W, Yan GX,. Electrical heterogeneity and the development of arrhythmias. In, Olsson SB, Yuan S, Amlie JP, (eds.): Dispersion of Ventricular Repolarization: State of the Art. Armonk, Futura Publishing Company, Inc., 2000.
32. Antzelevitch C,. Modulation of transmural repolarization. Ann N Y Acad Sci 2005; 1047: 314-323
33. Lazzerini PE, Capecchi PL, Guideri F, et al. Comparison of frequency of complex ventricular arrhythmias in patients with positive versus negative anti-Ro/SSA and connective tissue disease. Am J Cardiol 2007; 100: 1029-1034.
34. Barbhaiya C, Po JR, Hanon S, et al. Tpeak-Tend and Tpeak-Tend /QT ratio as markers of ventricular arrhythmia risk in cardiac resynchronization therapy patients. Pacing Clin Electrophysiol. 2013; 36: 103-108.
35. Lestas KP, Weber R, Astheimer K, et al. Tpeak-Tend interval and Tpeak-Tend/QT ratio as markers of ventricular tachycardia inducibility in subjects with Brugada ECG phenotype. Europace 2010; 12: 271-274.
36. Hevia JC, Antzelevitch C, Barzaga FT, et al. Rodriguez YF. Tpeak-Tend and Tpeak-Tend dispersion as risk factors for ventricular tachycardia/ventricular fibrillation in patients with the Brugada Syndrome. J Am Coll Cardiol 2006; 47: 1828-1834.
37. Braschi A, Ambrignani MG, Francavilla VC, et al. Novel electrocardiographic parameters of altered repolarization in uncomplicated overweight and obesity. Obesity 2011; 19: 875-881.
38. Demir M, Uyan U,. Evaluation of Tp-e interval and Tp-e/QT ratio in patients with non-dipper hypertension. Clin Exp Hypertens 2013. Jul 12 [Epub ahead of print].